Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Compare
0.0350
-0.0199
(-36.25%)
At close: April 1 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
34,133.6290
39,503.6360
28,228.7580
10,104.5130
2,434.6510
Operating Income
-34,133.6290
-39,503.6360
-28,228.7580
-10,104.5130
-2,434.6510
Net Non Operating Interest Income Expense
477.6940
498.9640
182.8020
-2.4140
-1,347.9370
Other Income Expense
651.5450
-239.2160
-194.7090
1,591.0550
--
Pretax Income
-33,004.3900
-39,243.8880
-28,240.6650
-8,515.8720
-3,782.5880
Tax Provision
10.1990
16.9490
20.7770
6.0040
0.8000
Net Income Common Stockholders
-33,014.5890
-39,260.8370
-28,261.4420
-8,521.8760
-3,783.3880
Diluted NI Available to Com Stockholders
-33,014.5890
-39,260.8370
-28,261.4420
-8,521.8760
-3,783.3880
Total Operating Income as Reported
-34,133.6290
-39,503.6360
-28,228.7580
-10,104.5130
-2,434.6510
Total Expenses
34,133.6290
39,503.6360
28,228.7580
10,104.5130
2,434.6510
Net Income from Continuing & Discontinued Operation
-33,014.5890
-39,260.8370
-28,261.4420
-8,521.8760
-3,783.3880
Normalized Income
-33,643.0553
-39,071.8564
-28,107.6219
-9,683.3462
-3,783.3880
Interest Income
471.0660
498.9640
182.8020
--
105.1830
Interest Expense
--
--
--
2.4140
1,453.1200
Net Interest Income
477.6940
498.9640
182.8020
-2.4140
-1,347.9370
EBIT
-33,270.7660
-39,503.6360
-28,228.7580
-8,513.4580
-2,329.4680
EBITDA
-33,270.7660
-39,503.6360
-28,228.7580
-8,513.4580
-2,328.8770
Reconciled Depreciation
--
--
--
--
0.5910
Net Income from Continuing Operation Net Minority Interest
-33,014.5890
-39,260.8370
-28,261.4420
-8,521.8760
-3,783.3880
Total Unusual Items Excluding Goodwill
795.5270
-239.2160
-194.7090
1,591.0550
--
Total Unusual Items
795.5270
-239.2160
-194.7090
1,591.0550
--
Normalized EBITDA
-34,066.2930
-39,264.4200
-28,034.0490
-10,104.5130
-2,328.8770
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
167.0607
-50.2354
-40.8889
429.5848
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APLMW Apollomics, Inc.
0.0108
0.00%
 
0QCO.IL Pharming Group N.V.
0.7485
-4.41%
 
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0228
-0.87%
 
IMTXW Immatics N.V.
0.0158
0.00%
 
LIXTW Lixte Biotechnology Holdings, Inc.
0.0338
0.00%
 
NLSPW NLS Pharmaceutics AG
0.0129
0.00%
 
ATNFW 180 Life Sciences Corp.
0.0070
-4.11%
 
LEXXW Lexaria Bioscience Corp.
0.3000
-7.69%
 
AIBT Aibotics Inc.
0.0500
+42.45%
 
ALZ.ST Alzinova AB (publ)
2.3200
-4.92%